Summary
The efficacy and safety of mifentidine 20 mg at night, a new, potent, long-acting H2-receptor antagonist, has been compared with ranitidine 300 mg at night in 60 patients with acute duodenal ulcer, in a randomized double-blind study. Antacid tablets were allowed as additional treatment for pain relief. The treatment lasted for 4 weeks.
After 4 weeks of treatment the healing rate was similar; amongst the patients who completed the treatment, healing was 68% for mifentidine, 63% for ranitidine, and on intention-to-treat analysis, healing in both groups was 63%. Pain relief and antacid consumption were similar in both groups.
Clinically significant adverse effects were not detected and any changes in laboratory values were minimal, clinically insignificant and reversible.
Mifentidine appears to be an effective and safe once-a-day treatment for acute duodenal ulcer disease.
References
Chiverton SG, Hunt RH (1988) Medical regimens in short and long-term ulcer management. Clin Gastroenterol 2: 655–676
Howden CW, Jones DB, Hunt RH (1985) Nocturnal doses of H2-receptor antagonist for duodenal ulcer. Lancet I: 647–648
Imbimbo BP, Urso R, Sturn B, Ueckert B, Vidi A, Ladinsky H, Daniotti S (1988) Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. Br J Clin Pharmacol 26: 407–413
Imbimbo BP, Seiberling M, Peukert U, Hoexter G, Maier-Lenz H, Vidi A, Daniotti S (1988) Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects. Eur J Clin Pharmacol 35: 673–676
Lazzaroni M, Ardizzone S, Imbimbo BP, Sangaletti O, Ghirardosi C, Bianchi Porro G (1987) Effect of mifentidine, a new H2-antagonist, on pentagastrin stimulated acid secretion in healthy subjects. Int J Clin Pharmacol Ther Toxicol 25: 218–221
Lazzaroni M, Imbimbo BP, Sangaletti O, Bianchi Porro G (1988) Gastric acid and pepsin secretion after single oral dose of mifentidine in healthy subjects. Scand J Gastroenterol 23: 788–792
Bianchi Porro G, Lazzaroni M, Imbimbo BP, Sangaletti O, Ghirardosi C, Daniotti S (1987) Action of mifentidine, a new H2-antagonist, on secretory response to sham feeding and pentagastrin and upon serum gastrin in duodenal ulcer patients. Eur J Clin Pharmacol 32: 555–558
Bianchi Porro G, Imbimbo BP, Lazzaroni M (1988) Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients. Agents Action 25: 222–226
Ireland A, Gear P, Colin-Jones DG, Golding PL, Ramage JK, Williams JG, Leicester RG, Smith CL, Ross G, Bamforth J, Degara CJ, Gledhill T, Hunt RH (1984) Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcer. Lancet II: 274–275
Simon B, Bianchi Porro G, Cremer M, Dobrilla G, Haglund U, Dunn SL, Summers K (1986) A single night-time dose of ranitidine 300 mg vs ranitidine 150 mg twice daily in the acute treatment of duodenal ulcer: a European multi-centre trial. J Clin Gastroenterol 8: 367–370
Gledhill T, Howard OM, Buck M, Paul A, Hunt RH (1983) Single nocturnal dose of an H2-receptor antagonist for the treatment of duodenal ulcer. Gut 24: 904–908
Sabbatini F, Piai G, Castiglione F, Petrelli G, Imbimbo BP, Mazzacca G (1988) Single daily doses of mifentidine on inhibition of intragastric acidity: controlled study vs ranitidine and placebo. Gastroenterology 94: A 392
Bianchi Porro G, Petrillo M, Lazzaroni M, Leto di Priolo S (1981) Healing of duodenal ulcer with twice daily oxmetidine. In: Baron JH (ed). Cimetidine in the 80's. Livingstone, Edinburgh, pp 27–33
Lauritsen K, Rune SJ, Wulff HR, Olsen JH, Laursen LS, Havelund T, Astrup L, Bendtsen F, Linde J, Bytzer P, Tage Jensen U, Gluud C, Andersen HH, Schlichting P, Skovbjerg A, Mertz-Nielsen A, Rask-Madsen J (1988) Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double-blind study comparative trial. Gut 29: 249–253
Misiewicz JJ (1978) Peptic ulceration and its correlation with symptoms. Clin Gastroenterol 7: 571–582
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbatini, F., Lazzaroni, M., Petrillo, M. et al. Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer. Eur J Clin Pharmacol 39, 515–517 (1990). https://doi.org/10.1007/BF00280946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280946